TST Dissolution Kinetics in the Surface-Reaction-Limited Regime of Low Drug-Loading ASDs

Two seemingly unrelated fields are meeting in an unexpected place: the chemistry of how volcanic glass slowly dissolves in seawater, and the science of making hard-to-dissolve drugs actually work in the body. Amorphous solid dispersions (ASDs) are a common pharmaceutical trick — you take a drug that normally won't dissolve well and blend it intimately with a polymer to keep it in a disordered, more dissoluble state. The catch is that predicting exactly how fast the drug releases is still more art than science. Meanwhile, geochemists have spent decades developing precise mathematical models for how volcanic glass breaks down in water, using a framework from physical chemistry called Transition State Theory (TST). This hypothesis proposes borrowing that volcanic glass equation — originally developed to understand ocean chemistry and rock weathering — and applying it to pharmaceutical drug release. The key insight is that at low drug concentrations in the formulation (below about 20%), the slowest step in dissolution isn't the drug diffusing away through water, but rather the breaking of hydrogen bonds between the drug and polymer molecules at the surface. That's chemically analogous to how silicate bonds break during volcanic glass dissolution. A dimensionless number called the Damköhler number (basically a ratio comparing reaction speed to diffusion speed) can tell you which regime you're in — and therefore which equation to use. The proposed mechanism is elegant: at low drug loadings, you can predict dissolution rates from measurable molecular properties like bond energies and the number of hydrogen bonds each drug molecule forms with the polymer. At high drug loadings, the old simpler diffusion model takes over. It's a unified framework that could turn a trial-and-error process into something more principled.

This is an AI-generated summary. Read the full mechanism below for technical detail.